首页>
外国专利>
Method for determining chemotherapeutic agent administration plan based on ERCC1 and TS expression
Method for determining chemotherapeutic agent administration plan based on ERCC1 and TS expression
展开▼
机译:基于ercc1和ts表达确定化疗药物给药方案的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object of the invention to provide a method for assessing TS and/or ERCC1 expression levels in fixed or fixed and paraffin embedded tissues and prognosticate the probable resistance of a patient's tumor to treatment with 5-FU and oxaliplatin-based therapies by examination of the amount of TS and/or ERCC1 mRNA in a patient's tumor cells and comparing it to a predetermined threshold expression level for those genes. More specifically, the invention provides to oligonucleotide primer pairs ERCC1 and TS and methods comprising their use for detecting levels of ERCC1 and TS mRNA, respectively.
展开▼